Authors

• Hans Chulhee Lee
• M Fry
• Malin L. Hultcrantz (ORCID: https://orcid.org/0000-0002-9045-6495)
• Jorge Mouro (ORCID: https://orcid.org/0000-0001-5978-9411)
• D. M. Kleinman
• Anna Lysén
• Leena Camadoo-O'Byrne
• Jacopo Bitetti
• Elisabetta Antonioli (ORCID: https://orcid.org/0000-0001-5547-3516)
• Thomas Melchardt (ORCID: https://orcid.org/0000-0002-0122-3631)
• M. Cavo
• Julie Byrne
• F Escalante
• Carla Y. Vossen
• Sandhya Sapra
• Ravi Vij
• Tim D’Estrube
• Meletios Dimopoulos
• Michel Delforge
• Victoria S. Benson
• Richard Greil
• Fredrik Schjesvold

Institutions

• Oslo University Hospital (NO)
• Memorial Sloan Kettering Cancer Center (US)
• The University of Texas MD Anderson Cancer Center (US)
• Providence College (US)
• National and Kapodistrian University of Athens (GR)
• Washington University in St. Louis (US)
• Paracelsus Medical University (AT)
• Age UK (GB)
• University of Rochester Medical Center (US)
• Syneos Health (United States) (US)
• Azienda Ospedaliero-Universitaria Careggi (IT)
• University of Teacher Education Zug (CH)
• Hospital Universitario de León (ES)
• University of Neuchâtel (CH)
• University of Bologna (IT)
• KU Leuven (BE)

Publication Details

Journal

Haematologica

Published

2026-01-22

DOI

https://doi.org/10.3324/haematol.2025.289034

Primary Topic

Multiple Myeloma Research and Treatments

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Amgen
• Bristol-Myers Squibb
• Eli Lilly and Company
• Pfizer
• AstraZeneca
• Sanofi
• Celgene
• Memorial Sloan-Kettering Cancer Center
• Novo Nordisk